CCEL CRYO CELL INTERNATIONAL INC
Updated
Healthcare · Services-Misc Health & Allied Services, Nec
CRYO CELL INTERNATIONAL INC (CCEL) is a healthcare company in the Services-Misc Health & Allied Services, Nec industry, with a market capitalization of $34 million. Shares last traded at $4.19, 33.0% below their 52-week high. Over the past year the stock is down 23.8%. Net profit margin is -7.9%, below the peer median of 6.0%. Revenue declined 1.3% year over year.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2026-05-31 · SEC EDGAR/XBRL.
CCEL Dividend History
| Fiscal year end | Total dividends paid | Per share* | Payout ratio |
|---|---|---|---|
| 2025-11-30 | $3M | $0.00 | — |
| 2024-11-30 | $2M | $0.00 | 503% |
| 2022-11-30 | $8M | $0.00 | 277% |
*Per share derived as total dividends paid ÷ weighted diluted shares (SEC EDGAR/XBRL annual cash-flow facts). Reported history — not a forecast of future dividends.
Compare payers on the highest-dividend-yield screener.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $0.07 | 2026-07-15 |
| Q1 2026 | $0.01 | 2026-04-14 |
| FY 2025 | $-0.30 | 2026-02-27 |
| Q3 2025 | $0.17 | 2025-10-15 |
| Q2 2026 | $0.08 | 2026-07-15 |
| Q1 2026 | $0.03 | 2026-04-14 |
Services-Misc Health & Allied Services, Nec peers
CCEL vs 11 industry peers (Services-Misc Health & Allied Services, Nec), by market cap. Updated
| DVA | DaVita | $11.6B | 13.69 | 0.83 | 6.0% | +1.37% |
| SHC | Sotera Health Co | $5.4B | 33.24 | 4.47 | 13.4% | +0.37% |
| PGNY | Progyny, Inc. | $2.0B | 25.98 | 1.56 | 6.0% | +1.31% |
| AGL | Agilon Health, Inc. | $1.4B | -6.24 | 0.24 | -3.9% | -1.43% |
| VMD | VIEMED HEALTHCARE, INC. | $343M | 23.67 | 1.14 | 4.8% | +0.22% |
| PARK | Park Dental Partners, Inc. | $97M | — | — | — | -2.47% |
| CCEL | CRYO CELL INTERNATIONAL INC | $34M | -13.70 | 1.09 | -7.9% | +0.24% |
| MGRX | MANGOCEUTICALS, INC. | $8M | -0.56 | 26.91 | — | +0.86% |
| BRTX | BioRestorative Therapies, Inc. | $4M | -0.33 | 10.18 | — | -29.73% |
| NIVF | NewGenIvf Group Ltd | — | — | — | — | -7.44% |
| FMS | Fresenius Medical Care Ag | — | — | — | 23.6% | -0.82% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.